| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers S > Headlines for SpectRx, Inc. > News item |
SpectRx awarded $690,000 NCI grant for cervical cancer detection
By Lisa Kerner
Charlotte, N.C., Sept. 13 - SpectRx, Inc. was awarded a $690,000 grant from the National Cancer Institute (NCI) to develop its non-invasive cervical cancer detection technology.
The company has been awarded five grants totaling $3.2 million from the NCI for the program.
"This latest grant should accelerate our clinical data collection and help us to complete the clinical trial necessary for a premarket approval application," chief technical officer Mark Faupel said in a news release.
The multi-center pivotal clinical trial of 1,100 subjects is underway at five U.S. health care facilities.
SpectRx is a diabetes management company based in Norcross, Ga.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.